Symbiotec Pharmalab IPO has entered its final bidding day with the issue subscribed 5.31 times and the grey market premium indicating a potential 29% listing gain over the upper price band.
Tag: IPO GMP
Hy-Tech vs Symbiotec vs Skyways: Which IPO Signals the Biggest Listing Gain?
Hy-Tech Engineers is leading the three IPOs in grey market premium terms after Day 3, with an implied 75.47% listing gain, ahead of Symbiotec Pharmalab and Skyways Air Services.
Hy-Tech Engineers IPO Sees 51x Demand as GMP Hits 57%
Hy-Tech Engineers IPO has drawn strong investor interest on Day 3, with the issue subscribed 51 times and the grey market premium indicating a potential 57% premium over the upper price band.